Authors: Korth-Bradley, JM Dowell, JA King, SP Liu, H Berger, MS

Citation: Jm. Korth-bradley et al., Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin, PHARMACOTHE, 21(10), 2001, pp. 1175-1180

Authors: Dowell, JA Korth-Bradley, J Milisci, M Tantillo, K Amorusi, P Tse, S

Citation: Ja. Dowell et al., Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment, J CLIN PHAR, 41(9), 2001, pp. 979-986

Authors: Dowell, JA Korth-Bradley, J Liu, HJ King, SP Berger, MS

Citation: Ja. Dowell et al., Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in firstrelapse, J CLIN PHAR, 41(11), 2001, pp. 1206-1214

Authors: Dowell, JA Sancho, AR Anand, D Wolf, W

Citation: Ja. Dowell et al., Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors, ADV DRUG DE, 41(1), 2000, pp. 111-126

Authors: Dowell, JA Hussain, A Devane, J Young, D

Citation: Ja. Dowell et al., Artificial neural networks applied to the in vitro in vivo correlation of an extended-release formulation: Initial trials and experience, J PHARM SCI, 88(1), 1999, pp. 154-160